Croda Europe Limited
Established in 1925, Croda is the name behind high performance ingredients and technologies in some of the world’s biggest and most successful brands: creating, making and selling speciality chemicals that are relied on by industries and consumers everywhere. They have a network of over 4,300 passionate and committed employees, working together as one global team across manufacturing sites and offices in 37 countries. Within the Health Care market, Croda offers high purity pharmaceutical excipients, highly performing vaccine adjuvants and in-house formulation expertise, making them the ideal solutions provider with whom to navigate drug and vaccine formulation challenges. Their product portfolio is proven to solubilise, stabilise and deliver the most challenging of active pharmaceutical ingredients, while high investment in GMP and multi-site EXCiPACT accreditation demonstrates confidence in both excipient quality and supply chain security.
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Affiliated categories:||Excipients |Drug Delivery Systems |Drug Formulation (general category) More|
CPhI Worldwide 20189 - 11 October 2018 Madrid, Spain We were at stand 8F80 See our Exhibitor Profile See full Exhibitor List
Our Top products
Super Refined™ Pharmaceutical Excipients for Topical Applications
a growing need to address the challenges that can affect topical drug delivery,
such as: API instability, poor API solubilisation and skin irritation that
reduces patient compliance.
Croda’s Super Refined™ excipients can maximise the value of topical drug products and ad...
Super Refined™ Pharmaceutical Excipients for Oral Applications
development often faces numerous challenges including: poor solubility,
formulation instability and ineffective drug delivery. The selection of the
right oral excipient during early phase development is critical to creating a
successful oral drug product.
Croda’s Super Refined™ e...
Super Refined™ Pharmaceutical Excipients for Parenteral Applications
of active pharmaceutical ingredients (APIs) for parenteral applications demands
the highest quality standards and attention to detail. Excipient selection is
critical to drug stability, formulation integrity and patient safety.
Croda’s Super Refined™ excipients offer multiple benefit...
News about Croda Europe Limited
25 Sep 2018
Croda to showcase ProSilic drug delivery technology
New technology will give Croda’s customers access to the next generation of targeted and controlled drug delivery.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation